Pharmaceutical metered dose inhaler and methods relating thereto

Details for Australian Patent Application No. 2004270171 (hide)

Owner Glaxo Group Limited

Inventors Sommerville, Mark Lee; Schultz, Robert David; Miller, John Francis

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004270171

PCT Pub. Number WO2005/023330

Priority 60/499,250 29.08.03 US

Filing date 25 August 2004

Wipo publication date 17 March 2005

International Classifications

A61M 15/00 (2006.01) Inhaling devices

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/023330 Priority application(s): WO2005/023330

9 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004270173-Automated method for producing improved orthodontic aligners

2004270170-Antibiotic product, use and formulation thereof